Cancer Research News: August 17 – August 31

  • Pfizer’s new lung cancer pill, crizotinib (Xalkori), was approved by the FDA, and is intended to treat patients with non-small cell lung cancer and the ALK gene.
  • Michigan State researchers have created Gene-Z, a device that works with an iPod Touch or Android tablet to analyze microRNAs to detect cancer quickly and cheaply.
  • A British cancer survival scale for patients in palliative care reliably predicted whether a patient had days, weeks, or months left to live.